Skip to main content
Premium Trial:

Request an Annual Quote

Cogenics to Serve as Astellas' Global Genotyping Provider

NEW YORK (GenomeWeb News) – Clinical Data’s Cogenics division will provide genotyping services to Tokyo-based drug developer Astellas Pharma, the company said today.
 
Under the agreement, Cogenics will serve as Astellas’ exclusive global provider of biorepository and extraction services and whole-genome association and targeted genotyping services for clinical studies in the US, Europe, and Asia.
 
Cogenics has facilities in North Carolina, Texas, the UK, France, and Germany.
 
Financial terms of the agreement were not released.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.